These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33739257)

  • 1. Paediatric tuberculosis during universal and selective
    Kontturi A; Kekomäki S; Soini H; Ollgren J; Salo E
    Euro Surveill; 2021 Mar; 26(11):. PubMed ID: 33739257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011-2021.
    Jackson S; Kabir Z; Comiskey C
    Vaccine; 2024 Mar; 42(8):2099-2105. PubMed ID: 38423810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in Childhood Nontuberculous Mycobacterial Infections After Bacille Calmette-Guérin Coverage Drop: A Nationwide, Population-Based Retrospective Study, Finland, 1995-2016.
    Kontturi A; Soini H; Ollgren J; Salo E
    Clin Infect Dis; 2018 Sep; 67(8):1256-1261. PubMed ID: 29584893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015.
    Abbott S; Christensen H; Welton NJ; Brooks-Pollock E
    Euro Surveill; 2019 Dec; 24(49):. PubMed ID: 31822330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries.
    Brantsaeter AB; Romanus V; Andersen PH; Heldal E
    Int J Tuberc Lung Dis; 2009 Apr; 13(4):440-5. PubMed ID: 19335948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette-Guérin vaccination.
    Kobayashi S; Yoshiyama T; Uchimura K; Hamaguchi Y; Kato S
    Sci Rep; 2021 Aug; 11(1):15902. PubMed ID: 34354146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of a change in infant BCG vaccination policy on adolescent TB incidence rates: A South African population-level cohort study.
    Fack C; Wood R; Hatherill M; Cobelens F; Hermans S
    Vaccine; 2022 Jan; 40(2):364-369. PubMed ID: 34872798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-specific effects of BCG vaccination on morbidity among children in Greenland: a population-based cohort study.
    Haahr S; Michelsen SW; Andersson M; Bjorn-Mortensen K; Soborg B; Wohlfahrt J; Melbye M; Koch A
    Int J Epidemiol; 2016 Dec; 45(6):2122-2130. PubMed ID: 28338723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.
    Sweeney E; Dahly D; Seddiq N; Corcoran G; Horgan M; Sadlier C
    BMC Infect Dis; 2019 May; 19(1):397. PubMed ID: 31072396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.
    Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
    Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
    Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
    Faust L; Schreiber Y; Bocking N
    BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG in Finland: changing from a universal to a selected programme.
    Salo EP
    Euro Surveill; 2006; 11(3):18-20. PubMed ID: 16567879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
    Fu H; Lin HH; Hallett TB; Arinaminpathy N
    Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland.
    Teljeur C; Moran PS; Harrington P; Butler K; Corcoran B; O'Donnell J; Usher C; O'Flanagan D; Connolly K; Ryan M
    Pediatr Infect Dis J; 2018 Aug; 37(8):759-767. PubMed ID: 29432385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten Years' Experience with the Discontinuation of the Bacillus Calmette-Guérin Vaccination in the Czech Republic.
    Doležalová K; Göpfertová D
    Int J Mycobacteriol; 2021; 10(2):193-198. PubMed ID: 34558474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of universal BCG vaccination of Japanese infants.
    Rahman M; Sekimoto M; Takamatsu I; Hira K; Shimbo T; Toyoshima K; Fukui T
    Int J Epidemiol; 2001 Apr; 30(2):380-5. PubMed ID: 11369746
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.